Helping a diagnostic company to advance implementation in ESG commitments

Biopharma

Jan 16

Written By Tetiana Kosten

Expanding the growth opportunities of an education platform into alternative medicine space in Germany

Engaging payers in the rare disease space to prepare the market environment for the entry of a gene therapy